Benitec Biopharma Ltd (BNTC.OQ)
3.18USD
19 Apr 2018
-- (--)
$3.18
--
--
--
--
4,483
$4.15
$1.85
Latest Key Developments (Source: Significant Developments)
Benitec Biopharma Says U.S. FDA Granted Orphan Drug Designation To BB-301
Jan 15 (Reuters) - Benitec Biopharma Ltd
Benitec Biopharma Posts Qtrly Loss Of A$2.9 mln
Nov 29 (Reuters) - Benitec Biopharma Ltd
Benitec Biopharma says appoints Jerel Banks as chairman
Oct 12 (Reuters) - Benitec Biopharma Ltd
Benitec Biopharma says Greg West appointed CEO
Benitec Biopharma Ltd
Benitec Biopharma appoints Greg West as chief executive officer
Benitec Biopharma Ltd
Benitec Biopharma receives cash refund under government's R&D tax incentive scheme
Benitec Biopharma Ltd
BRIEF-Benitec Biopharma Says U.S. FDA Granted Orphan Drug Designation To BB-301
* U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD) Source text for Eikon: Further company coverage: